Credit Suisse Group AG initiated coverage on shares of AC Immune Ltd (NASDAQ:ACIU) in a research note issued to investors on Tuesday morning. The firm issued an outperform rating and a $18.00 price target on the stock.

Separately, Jefferies Group began coverage on shares of AC Immune in a research report on Tuesday. They set a buy rating and a $25.00 price target on the stock.

Shares of AC Immune (NASDAQ:ACIU) traded down 1.38% during mid-day trading on Tuesday, hitting $14.98. 11,634 shares of the company’s stock traded hands. The company has a market cap of $739.95 million and a PE ratio of 32.35. The firm has a 50-day moving average of $16.11 and a 200 day moving average of $16.11. AC Immune has a 52 week low of $13.01 and a 52 week high of $19.97.

5 Day Chart for NASDAQ:ACIU

Receive News & Stock Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related stocks with our FREE daily email newsletter.